Addus HomeCare CorpADUS
Price$110.54Intrinsic value$157.2142% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $157.21median of 6 methods · middle span $100-$196based on filings through 30 Jun 2026
Market Price $110.54Price as of 30 Sep 2026
Margin of Safety +42.2%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 11.0% (near-term consensus, capped) · years 2–5: 8.1%/yr (balance of the path).8.7% per year
Years 6–10: glide to demonstrated growth own history 20.2%, capped at 20%
Per-year rates
Yr 68.2%Yr 78.3%Yr 88.4%Yr 98.5%Yr 108.7%
8.1% → 8.7%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.1%Yr 127.5%Yr 137.0%Yr 146.4%Yr 155.8%Yr 165.3%Yr 174.7%Yr 184.1%Yr 193.6%Yr 203.0%
8.7% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)20.2%
Discount rate (cost of equity) 9.1%
Volatility vs market (adjusted beta)0.91

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAddus HomeCare CorpADUSHealth Care
Valuation
P/E19.4×
P/S1.5×
P/B1.9×
EV / Revenue1.5×
EV / EBITDA10.0×
Profitability
Gross margin32.4%
Operating margin9.7%
Net margin7.1%
FCF margin10.5%
Returns
ROE9.2%
ROA7.2%
ROIC9.5%
Growth
Revenue growth (YoY)27.9%
5-yr fwd EPS growth8.7%
Financial strength
Debt / Equity0.05×
Current ratio1.69×
Altman Z-Score6.1
Interest coverage90.33×
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.